Huadong Medicine Co., Ltd (000963.SZ)
CNY 36.19
(0.56%)
CNY 36.19
(0.56%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 4.02 Billion | 2.38 Billion | 3.16 Billion | 3.41 Billion | 2 Billion | 2.03 Billion |
| Net Income | 2.83 Billion | 2.53 Billion | 2.33 Billion | 2.9 Billion | 2.92 Billion | 2.39 Billion |
| Depreciation & Amortization | 818.34 Million | 705.54 Million | 591.56 Million | 431 Million | 404.47 Million | 319.05 Million |
| Deferred income taxes | -52.38 Million | 8.4 Million | 22.35 Million | 27.46 Million | 711.65 Thousand | 5.65 Million |
| Stock-based compensation | 43.01 Million | - | - | 4.89 Million | - | - |
| Change in working capital | -69.57 Million | -1.12 Billion | 35.44 Million | 256.58 Million | -1.34 Billion | -802.54 Million |
| Other non-cash items | 2.19 Billion | 255.89 Million | 204.12 Million | -218.22 Million | 15.53 Million | 127.81 Million |
| Investing Cash Flow | -1.82 Billion | -2.43 Billion | -1.98 Billion | -1.73 Billion | -1.58 Billion | -1.56 Billion |
| Investments in PPE | -1.6 Billion | -1.19 Billion | -819.09 Million | -1.47 Billion | -1.35 Billion | -876.46 Million |
| Acquisitions | -94.63 Million | -411.9 Million | -791.85 Million | 373.8 Million | -11.19 Million | -1.45 Billion |
| Investment purchases | -221.47 Million | -848.9 Million | -246.4 Million | -638.46 Million | -256.94 Million | 1.29 |
| Sales/Maturities of investments | 2.08 Million | 100.32 Million | 136.1 Million | 900 Thousand | 6.37 Million | 21.37 Million |
| Other Investing Activities | 100.57 Million | -81.86 Million | -265.43 Million | -1.89 Million | 32.6 Million | 751.5 Million |
| Financing Cash Flow | -1.41 Billion | -99.71 Million | -767.45 Million | -725.73 Million | -608.59 Million | -430.43 Million |
| Debt repayment | -567.89 Million | -4.29 Billion | -2.29 Billion | -2.25 Billion | -1.88 Billion | -1.67 Billion |
| Dividends payments | -508.65 Million | -507.44 Million | -402.45 Million | -489.94 Million | -481.19 Million | -769.17 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -244.53 Million | 4.76 Billion | 1.98 Billion | 2.09 Billion | 1.84 Billion | 2.01 Billion |
| Accounts receivables | -968.97 Million | -2.09 Billion | -775.57 Million | -530.3 Million | -815.95 Million | -585.49 Million |
| Accounts payables | 685.55 Million | 1.45 Billion | 770.57 Million | 797.16 Million | -368.86 Million | 187.17 Million |
| Inventory | 213.84 Million | -491.51 Million | 18.08 Million | -37.72 Million | -159.6 Million | -409.87 Million |
| Other working capital | 1.00 | 8.4 Million | 22.35 Million | 27.46 Million | 711.65 Thousand | -392.67 Million |
| Cash at beginning of period | 3.99 Billion | 3.58 Billion | 3.15 Billion | 2.23 Billion | 2.39 Billion | 2.37 Billion |
| Cash at end of period | 4.66 Billion | 3.41 Billion | 3.58 Billion | 3.15 Billion | 2.23 Billion | 2.39 Billion |
| Capital Expenditure | -1.6 Billion | -1.19 Billion | -819.09 Million | -1.47 Billion | -1.35 Billion | -876.46 Million |
| Effect of forex changes on cash | 5.94 Million | -9.77 Million | 7.11 Million | -21.44 Million | 22.56 Million | -22.42 Million |
| Net cash flow / Change in cash | 667.07 Million | -163.22 Million | 422.73 Million | 925.63 Million | -166.93 Million | 25.88 Million |
| Free Cash Flow | 2.41 Billion | 1.18 Billion | 2.35 Billion | 1.93 Billion | 648.25 Million | 1.16 Billion |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 866.3 Million | 833.6 Million | 862.41 Million | 2.83 Billion | 649.81 Million | 755.22 Million |
| Depreciation & Amortization | - | 214.04 Million | 214.04 Million | 818.34 Million | 213.15 Million | -381.64 Million |
| Deferred income taxes | - | - | - | -52.38 Million | 669.1 Million | - |
| Stock-based compensation | - | - | - | 43.01 Million | 43.01 Million | - |
| Change in working capital | - | - | - | -69.57 Million | -712.11 Million | 806.63 Million |
| Other non-cash items | -617.85 Million | 2.16 Billion | -1.34 Billion | 2.19 Billion | 1.5 Billion | -952.67 Million |
| Investing Cash Flow | -934.95 Million | 11.97 Million | -709.37 Million | -1.82 Billion | -795.64 Million | -370.23 Million |
| Investments in PPE | -272.44 Million | -185.76 Million | -472.27 Million | -1.6 Billion | -646.44 Million | -362.53 Million |
| Acquisitions | -353.23 Million | 21.62 Million | -14.67 Million | -94.63 Million | 37.79 Million | -7.86 Million |
| Investment purchases | -4.7 Million | -81.79 Million | -65.86 Million | -221.47 Million | -150 Million | -18.68 Million |
| Sales/Maturities of investments | 15.3 Million | 2 Million | 1 Million | 2.08 Million | 2.08 Million | 150.66 Thousand |
| Other Investing Activities | -673.1 Million | -44.25 Thousand | -157.56 Million | 100.57 Million | -39.08 Million | 18.69 Million |
| Financing Cash Flow | -674.18 Million | -558.72 Million | 71.49 Million | -1.41 Billion | -200.04 Million | -291.82 Million |
| Debt repayment | -48.92 Million | -142.27 Million | -307.84 Million | -567.89 Million | -16.23 Million | -1.64 Billion |
| Dividends payments | -1.01 Billion | -1.01 Billion | -36.43 Million | -508.65 Million | -508.65 Million | -37.86 Million |
| Common Stock Repurchased | - | - | - | - | -175 Thousand | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -57.01 Million | 360.32 Million | -236.34 Million | -244.53 Million | 389.65 Million | 1.39 Billion |
| Accounts receivables | - | - | - | -968.97 Million | -968.97 Million | 702.09 Million |
| Accounts payables | - | - | - | 685.55 Million | - | - |
| Inventory | - | - | - | 213.84 Million | 213.84 Million | 104.53 Million |
| Other working capital | - | - | - | 1.00 | 43.01 Million | - |
| Cash at beginning of period | 5.32 Billion | 3.56 Billion | 4.66 Billion | 3.99 Billion | 3.93 Billion | 3.94 Billion |
| Cash at end of period | 3.97 Billion | 5.65 Billion | 3.56 Billion | 4.66 Billion | 4.66 Billion | 3.47 Billion |
| Capital Expenditure | -272.44 Million | -185.76 Million | -472.27 Million | -1.6 Billion | -646.44 Million | -362.53 Million |
| Effect of forex changes on cash | 27.15 Million | -23.17 Million | 17.39 Million | 5.94 Million | 26.43 Million | -29.43 Million |
| Net cash flow / Change in cash | -1.35 Billion | 2.08 Billion | -1.1 Billion | 667.07 Million | 733.32 Million | -463.96 Million |
| Free Cash Flow | -23.99 Million | 2.59 Billion | -954.79 Million | 2.41 Billion | 1.05 Billion | -134.99 Million |
ZOG
TMG
NXGPY
SBSW
NAR
LCOMF